Literature DB >> 7297039

Urinary excretion of bile acids in cholestasis: evidence for renal tubular secretion in man.

C L Corbett, T C Bartholomew, B H Billing, J A Summerfield.   

Abstract

1. The apparent renal clearance of intravenously injected [14C]glycocholate and [3H]chenodeoxycholate-3-sulphate was estimated in 22 patients with cholestasis. The degree of protein binding of the isotopes in serum from these patients was determined. The effects of pharmacological agents, changes in urine flow rate and pH on renal clearance was studied. 2. The mean renal clearance of [14C]glycocholate was 1 . 7 +/- 0 . 4 ml/min (mean +/- SEM), and that of [3H]chenodeoxycholate-3-sulphate was 6 . 4 +/- 0 . 9 ml/min. [14C]Glycocholate was 80 . 1% protein bound and [3H]chenodeoxycholate-3-sulphate 96 . 5% protein bound. 3. Comparisons of the observed clearance rates with those calculated on the basis of glomerular filtration of the unbound fraction suggest that whereas [14C]glycocholate is predominantly reabsorbed by the renal tubules, [3H]chenodeoxycholate-3-sulphate appears in the urine mainly as the result of tubular secretion. 4. Probenecid, ethacrynic acid, frusemide and bendrofluazide decreased the clearance of both bile acids, implying competition for secretion via the proximal tubular organic acid secretory pathway between these compounds and bile acids. 5. Passive non-ionic diffusion does not seem to be an important mechanism in the renal excretion of bile acids as changes in urine flow rate and pH did not influence bile acid clearance. 6. A greater affinity of the proximal tubular organic acid secretory pathway for sulphated than for non-sulphated bile acids may explain the higher observed renal clearance rate of sulphated bile acids.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7297039     DOI: 10.1042/cs0610773

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  5 in total

1.  Chronic renal failure-induced changes in serum and urine bile acid profiles.

Authors:  F Jimenez; M J Monte; M Y El-Mir; M J Pascual; J J G Marin
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

Review 2.  Role of the intestinal bile acid transporters in bile acid and drug disposition.

Authors:  Paul A Dawson
Journal:  Handb Exp Pharmacol       Date:  2011

Review 3.  Bile acid transporters.

Authors:  Paul A Dawson; Tian Lan; Anuradha Rao
Journal:  J Lipid Res       Date:  2009-06-04       Impact factor: 5.922

4.  Exploratory metabolomics study of the experimental opisthorchiasis in a laboratory animal model (golden hamster, Mesocricetus auratus).

Authors:  Daria A Kokova; Sarantos Kostidis; Judit Morello; Nataly Dementeva; Ekaterina A Perina; Vladimir V Ivanov; Ludmila M Ogorodova; Aleksey E Sazonov; Irina V Saltykova; Oleg A Mayboroda
Journal:  PLoS Negl Trop Dis       Date:  2017-10-31

Review 5.  Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression.

Authors:  Aline Gottlieb; Ali Canbay
Journal:  Cells       Date:  2019-10-30       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.